In their recently-released Life Science Stars listing, LMG Life Sciences included Dr. Kirsten Grüneberg as an outstanding individual in patent prosecution.

Each year, LMG Life Sciences releases a thoroughly-vetted guide to leading attorneys in North America specialized in the life sciences. Recognizing that only an elite group can expertly balance the complexities of the legal market and the life sciences industry, the list accounts for three key criteria: case evidence, peer feedback, and client feedback.

Dr. Grüneberg’s inclusion in this year’s list recognizes the strong and growing life sciences practice at the Grüneberg and Myers firm. Now more than three years since its inception, the firm has already counseled clients on such wide-ranging issues as Hatch-Waxman exclusivity, Patent Term Extension, Orange Book listings, Biologics Price Competition and Innovation Act strategy, and patent subject matter eligibility for diagnostics.

For more information, please see Dr. Grüneberg’s listing on the LMG Life Sciences website.

Launched in September 2017, Grüneberg and Myers PLLC is a 100 percent female- and minority-owned international patent firm. With a broad and sophisticated practice, the firm provides a full range of patent support services, including patent prosecution, counseling, post-grant representation, and M&A due diligence to meet the growing and diverse needs of U.S.-based, European, and Asian companies, entrepreneurs, and inventors.